Send me a link:

*Text messaging rates may apply.

 Dow Down 0.42% Nasdaq Down 0.05%

Sunesis Pharmaceuticals, Inc. (SNSS)

-NasdaqCM
6.78 Up 0.09(1.35%) Jul 29, 3:59PM EDT
Prev Close:6.69
Open:6.69
Bid:6.25 x 2000
Ask:7.00 x 200
1y Target Est:12.14
Beta:2.94
Next Earnings Date:N/A
Day's Range:6.66 - 6.87
52wk Range:3.84 - 7.49
Volume:480,289
Avg Vol (3m):411,583
Market Cap:408.27M
P/E (ttm):N/A
EPS (ttm):-0.70
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for SNSS

Comparison

Symbol% ChgMkt Cap
SNSSUp 1.35%408.27M
AZNDown 1.06%92.19B
PFEDown 1.23%189.64B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):50.60
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.72
Quarterly EPS Est (Jun-14) :-0.17
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Sunesis Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of oncology therapeutics for the treatment of solid and hematologic cancers. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback